nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—POR—Doxorubicin—ovarian cancer	0.493	0.648	CbGbCtD
Benzphetamine—CYP3A4—Topotecan—ovarian cancer	0.0724	0.0952	CbGbCtD
Benzphetamine—CYP2B6—Doxorubicin—ovarian cancer	0.0629	0.0827	CbGbCtD
Benzphetamine—CYP3A4—Vinorelbine—ovarian cancer	0.051	0.0671	CbGbCtD
Benzphetamine—CYP3A4—Paclitaxel—ovarian cancer	0.0358	0.0472	CbGbCtD
Benzphetamine—CYP3A4—Docetaxel—ovarian cancer	0.0259	0.0341	CbGbCtD
Benzphetamine—CYP3A4—Doxorubicin—ovarian cancer	0.0193	0.0254	CbGbCtD
Benzphetamine—Digestion impaired—Chlorambucil—ovarian cancer	0.00629	0.0577	CcSEcCtD
Benzphetamine—POR—myometrium—ovarian cancer	0.00576	0.0629	CbGeAlD
Benzphetamine—Digestion impaired—Melphalan—ovarian cancer	0.00549	0.0503	CcSEcCtD
Benzphetamine—POR—uterine cervix—ovarian cancer	0.00448	0.0489	CbGeAlD
Benzphetamine—SLC18A2—uterine cervix—ovarian cancer	0.00427	0.0466	CbGeAlD
Benzphetamine—POR—decidua—ovarian cancer	0.00427	0.0466	CbGeAlD
Benzphetamine—Cardiomyopathy—Paclitaxel—ovarian cancer	0.00421	0.0386	CcSEcCtD
Benzphetamine—POR—endometrium—ovarian cancer	0.00405	0.0443	CbGeAlD
Benzphetamine—Anorexia—Altretamine—ovarian cancer	0.00403	0.0369	CcSEcCtD
Benzphetamine—SLC18A2—endometrium—ovarian cancer	0.00386	0.0422	CbGeAlD
Benzphetamine—Decreased appetite—Altretamine—ovarian cancer	0.00367	0.0337	CcSEcCtD
Benzphetamine—SLC18A2—uterus—ovarian cancer	0.00356	0.0389	CbGeAlD
Benzphetamine—SLC18A2—female reproductive system—ovarian cancer	0.0032	0.0349	CbGeAlD
Benzphetamine—POR—bone marrow—ovarian cancer	0.00317	0.0346	CbGeAlD
Benzphetamine—POR—female gonad—ovarian cancer	0.00305	0.0334	CbGeAlD
Benzphetamine—POR—vagina—ovarian cancer	0.00304	0.0332	CbGeAlD
Benzphetamine—SLC18A2—vagina—ovarian cancer	0.00289	0.0316	CbGeAlD
Benzphetamine—Dizziness—Altretamine—ovarian cancer	0.00279	0.0256	CcSEcCtD
Benzphetamine—POR—testis—ovarian cancer	0.00271	0.0296	CbGeAlD
Benzphetamine—SLC18A2—testis—ovarian cancer	0.00258	0.0282	CbGeAlD
Benzphetamine—Nausea—Altretamine—ovarian cancer	0.00251	0.023	CcSEcCtD
Benzphetamine—SLC6A2—decidua—ovarian cancer	0.00248	0.0271	CbGeAlD
Benzphetamine—ADRA1A—epithelium—ovarian cancer	0.00244	0.0267	CbGeAlD
Benzphetamine—Cardiomyopathy—Epirubicin—ovarian cancer	0.00241	0.0221	CcSEcCtD
Benzphetamine—ADRA2A—myometrium—ovarian cancer	0.00237	0.0259	CbGeAlD
Benzphetamine—Cardiomyopathy—Doxorubicin—ovarian cancer	0.00223	0.0204	CcSEcCtD
Benzphetamine—SLC6A2—gonad—ovarian cancer	0.00219	0.0239	CbGeAlD
Benzphetamine—Sweating—Topotecan—ovarian cancer	0.00201	0.0184	CcSEcCtD
Benzphetamine—POR—lymph node—ovarian cancer	0.00196	0.0214	CbGeAlD
Benzphetamine—SLC6A3—testis—ovarian cancer	0.00195	0.0213	CbGeAlD
Benzphetamine—SLC6A2—female reproductive system—ovarian cancer	0.00195	0.0213	CbGeAlD
Benzphetamine—SLC18A2—lymph node—ovarian cancer	0.00187	0.0204	CbGeAlD
Benzphetamine—ADRA2A—uterine cervix—ovarian cancer	0.00184	0.0201	CbGeAlD
Benzphetamine—ADRA2A—decidua—ovarian cancer	0.00175	0.0192	CbGeAlD
Benzphetamine—Tremor—Chlorambucil—ovarian cancer	0.00172	0.0158	CcSEcCtD
Benzphetamine—Agitation—Chlorambucil—ovarian cancer	0.00169	0.0155	CcSEcCtD
Benzphetamine—ADRA2A—endometrium—ovarian cancer	0.00167	0.0182	CbGeAlD
Benzphetamine—CYP2B6—gonad—ovarian cancer	0.00161	0.0176	CbGeAlD
Benzphetamine—SLC6A2—testis—ovarian cancer	0.00158	0.0172	CbGeAlD
Benzphetamine—ADRA2A—gonad—ovarian cancer	0.00155	0.0169	CbGeAlD
Benzphetamine—ADRA2A—uterus—ovarian cancer	0.00153	0.0168	CbGeAlD
Benzphetamine—CYP2B6—female reproductive system—ovarian cancer	0.00144	0.0157	CbGeAlD
Benzphetamine—Anorexia—Chlorambucil—ovarian cancer	0.00143	0.0131	CcSEcCtD
Benzphetamine—ADRA2A—female reproductive system—ovarian cancer	0.00138	0.0151	CbGeAlD
Benzphetamine—Dyspepsia—Chlorambucil—ovarian cancer	0.00132	0.0121	CcSEcCtD
Benzphetamine—Decreased appetite—Chlorambucil—ovarian cancer	0.0013	0.012	CcSEcCtD
Benzphetamine—CYP2B6—vagina—ovarian cancer	0.0013	0.0142	CbGeAlD
Benzphetamine—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.0013	0.0119	CcSEcCtD
Benzphetamine—Hyperhidrosis—Topotecan—ovarian cancer	0.00129	0.0119	CcSEcCtD
Benzphetamine—Tachycardia—Melphalan—ovarian cancer	0.00128	0.0117	CcSEcCtD
Benzphetamine—Anorexia—Topotecan—ovarian cancer	0.00127	0.0117	CcSEcCtD
Benzphetamine—ADRA2A—female gonad—ovarian cancer	0.00126	0.0137	CbGeAlD
Benzphetamine—ADRA2A—vagina—ovarian cancer	0.00125	0.0136	CbGeAlD
Benzphetamine—Anorexia—Melphalan—ovarian cancer	0.00125	0.0114	CcSEcCtD
Benzphetamine—Palpitations—Vinorelbine—ovarian cancer	0.00124	0.0114	CcSEcCtD
Benzphetamine—Urticaria—Chlorambucil—ovarian cancer	0.00119	0.0109	CcSEcCtD
Benzphetamine—Dyspepsia—Topotecan—ovarian cancer	0.00118	0.0108	CcSEcCtD
Benzphetamine—Decreased appetite—Topotecan—ovarian cancer	0.00116	0.0107	CcSEcCtD
Benzphetamine—CYP2B6—testis—ovarian cancer	0.00116	0.0127	CbGeAlD
Benzphetamine—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00115	0.0106	CcSEcCtD
Benzphetamine—Dyspepsia—Melphalan—ovarian cancer	0.00115	0.0106	CcSEcCtD
Benzphetamine—SLC6A2—lymph node—ovarian cancer	0.00114	0.0125	CbGeAlD
Benzphetamine—Decreased appetite—Melphalan—ovarian cancer	0.00114	0.0104	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00113	0.0104	CcSEcCtD
Benzphetamine—Tachycardia—Vinorelbine—ovarian cancer	0.00112	0.0102	CcSEcCtD
Benzphetamine—ADRA2A—testis—ovarian cancer	0.00111	0.0122	CbGeAlD
Benzphetamine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00111	0.0101	CcSEcCtD
Benzphetamine—Anorexia—Vinorelbine—ovarian cancer	0.00109	0.01	CcSEcCtD
Benzphetamine—CYP3A4—female reproductive system—ovarian cancer	0.00109	0.0119	CbGeAlD
Benzphetamine—Urticaria—Topotecan—ovarian cancer	0.00106	0.00974	CcSEcCtD
Benzphetamine—Toremifene—ESR1—ovarian cancer	0.00106	0.226	CrCbGaD
Benzphetamine—Urticaria—Melphalan—ovarian cancer	0.00104	0.00954	CcSEcCtD
Benzphetamine—Diarrhoea—Chlorambucil—ovarian cancer	0.00103	0.00942	CcSEcCtD
Benzphetamine—Decreased appetite—Vinorelbine—ovarian cancer	0.000994	0.00912	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000987	0.00905	CcSEcCtD
Benzphetamine—Hypersensitivity—Topotecan—ovarian cancer	0.000984	0.00903	CcSEcCtD
Benzphetamine—Hypersensitivity—Melphalan—ovarian cancer	0.000964	0.00884	CcSEcCtD
Benzphetamine—Diarrhoea—Topotecan—ovarian cancer	0.000914	0.00839	CcSEcCtD
Benzphetamine—Urticaria—Vinorelbine—ovarian cancer	0.000908	0.00833	CcSEcCtD
Benzphetamine—Diarrhoea—Melphalan—ovarian cancer	0.000895	0.00821	CcSEcCtD
Benzphetamine—Nausea—Chlorambucil—ovarian cancer	0.000892	0.00818	CcSEcCtD
Benzphetamine—Dizziness—Topotecan—ovarian cancer	0.000884	0.00811	CcSEcCtD
Benzphetamine—Tremor—Paclitaxel—ovarian cancer	0.000883	0.0081	CcSEcCtD
Benzphetamine—Agitation—Paclitaxel—ovarian cancer	0.000866	0.00794	CcSEcCtD
Benzphetamine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000842	0.00773	CcSEcCtD
Benzphetamine—Headache—Topotecan—ovarian cancer	0.000837	0.00768	CcSEcCtD
Benzphetamine—Palpitations—Paclitaxel—ovarian cancer	0.000832	0.00764	CcSEcCtD
Benzphetamine—ADRA2A—lymph node—ovarian cancer	0.000807	0.00882	CbGeAlD
Benzphetamine—Nausea—Topotecan—ovarian cancer	0.000794	0.00728	CcSEcCtD
Benzphetamine—Diarrhoea—Vinorelbine—ovarian cancer	0.000782	0.00718	CcSEcCtD
Benzphetamine—Nausea—Melphalan—ovarian cancer	0.000777	0.00713	CcSEcCtD
Benzphetamine—Dizziness—Vinorelbine—ovarian cancer	0.000756	0.00694	CcSEcCtD
Benzphetamine—Tachycardia—Paclitaxel—ovarian cancer	0.00075	0.00689	CcSEcCtD
Benzphetamine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000743	0.00682	CcSEcCtD
Benzphetamine—Anorexia—Paclitaxel—ovarian cancer	0.000733	0.00672	CcSEcCtD
Benzphetamine—Headache—Vinorelbine—ovarian cancer	0.000716	0.00657	CcSEcCtD
Benzphetamine—Palpitations—Docetaxel—ovarian cancer	0.000706	0.00647	CcSEcCtD
Benzphetamine—Insomnia—Paclitaxel—ovarian cancer	0.000695	0.00638	CcSEcCtD
Benzphetamine—Nausea—Vinorelbine—ovarian cancer	0.000679	0.00623	CcSEcCtD
Benzphetamine—Dyspepsia—Paclitaxel—ovarian cancer	0.000677	0.00621	CcSEcCtD
Benzphetamine—Decreased appetite—Paclitaxel—ovarian cancer	0.000668	0.00613	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000664	0.00609	CcSEcCtD
Benzphetamine—Sweating—Epirubicin—ovarian cancer	0.000661	0.00606	CcSEcCtD
Benzphetamine—Tachycardia—Docetaxel—ovarian cancer	0.000636	0.00584	CcSEcCtD
Benzphetamine—Tamoxifen—CYP1B1—ovarian cancer	0.000626	0.134	CrCbGaD
Benzphetamine—Anorexia—Docetaxel—ovarian cancer	0.000621	0.0057	CcSEcCtD
Benzphetamine—Sweating—Doxorubicin—ovarian cancer	0.000611	0.00561	CcSEcCtD
Benzphetamine—Urticaria—Paclitaxel—ovarian cancer	0.000611	0.0056	CcSEcCtD
Benzphetamine—Insomnia—Docetaxel—ovarian cancer	0.000589	0.00541	CcSEcCtD
Benzphetamine—Dyspepsia—Docetaxel—ovarian cancer	0.000574	0.00526	CcSEcCtD
Benzphetamine—Decreased appetite—Docetaxel—ovarian cancer	0.000566	0.0052	CcSEcCtD
Benzphetamine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000566	0.0052	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000563	0.00516	CcSEcCtD
Benzphetamine—Diarrhoea—Paclitaxel—ovarian cancer	0.000526	0.00483	CcSEcCtD
Benzphetamine—Dizziness—Paclitaxel—ovarian cancer	0.000508	0.00467	CcSEcCtD
Benzphetamine—Agitation—Epirubicin—ovarian cancer	0.000495	0.00454	CcSEcCtD
Benzphetamine—Headache—Paclitaxel—ovarian cancer	0.000482	0.00442	CcSEcCtD
Benzphetamine—Hypersensitivity—Docetaxel—ovarian cancer	0.00048	0.00441	CcSEcCtD
Benzphetamine—Palpitations—Epirubicin—ovarian cancer	0.000476	0.00437	CcSEcCtD
Benzphetamine—Agitation—Doxorubicin—ovarian cancer	0.000458	0.0042	CcSEcCtD
Benzphetamine—Nausea—Paclitaxel—ovarian cancer	0.000457	0.00419	CcSEcCtD
Benzphetamine—Toremifene—ABCB1—ovarian cancer	0.00045	0.0961	CrCbGaD
Benzphetamine—Diarrhoea—Docetaxel—ovarian cancer	0.000446	0.00409	CcSEcCtD
Benzphetamine—Palpitations—Doxorubicin—ovarian cancer	0.00044	0.00404	CcSEcCtD
Benzphetamine—Dizziness—Docetaxel—ovarian cancer	0.000431	0.00395	CcSEcCtD
Benzphetamine—Tachycardia—Epirubicin—ovarian cancer	0.000429	0.00394	CcSEcCtD
Benzphetamine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000425	0.0039	CcSEcCtD
Benzphetamine—Tamoxifen—ESR1—ovarian cancer	0.000423	0.0903	CrCbGaD
Benzphetamine—Anorexia—Epirubicin—ovarian cancer	0.000419	0.00384	CcSEcCtD
Benzphetamine—Headache—Docetaxel—ovarian cancer	0.000408	0.00375	CcSEcCtD
Benzphetamine—Insomnia—Epirubicin—ovarian cancer	0.000398	0.00365	CcSEcCtD
Benzphetamine—Tachycardia—Doxorubicin—ovarian cancer	0.000397	0.00364	CcSEcCtD
Benzphetamine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000393	0.00361	CcSEcCtD
Benzphetamine—Anorexia—Doxorubicin—ovarian cancer	0.000388	0.00356	CcSEcCtD
Benzphetamine—Nausea—Docetaxel—ovarian cancer	0.000387	0.00355	CcSEcCtD
Benzphetamine—Dyspepsia—Epirubicin—ovarian cancer	0.000387	0.00355	CcSEcCtD
Benzphetamine—Decreased appetite—Epirubicin—ovarian cancer	0.000382	0.00351	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000379	0.00348	CcSEcCtD
Benzphetamine—Insomnia—Doxorubicin—ovarian cancer	0.000368	0.00338	CcSEcCtD
Benzphetamine—Dyspepsia—Doxorubicin—ovarian cancer	0.000358	0.00328	CcSEcCtD
Benzphetamine—Decreased appetite—Doxorubicin—ovarian cancer	0.000354	0.00324	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000351	0.00322	CcSEcCtD
Benzphetamine—Urticaria—Epirubicin—ovarian cancer	0.000349	0.0032	CcSEcCtD
Benzphetamine—Hypersensitivity—Epirubicin—ovarian cancer	0.000324	0.00297	CcSEcCtD
Benzphetamine—Urticaria—Doxorubicin—ovarian cancer	0.000323	0.00296	CcSEcCtD
Benzphetamine—Propafenone—ABCB1—ovarian cancer	0.000317	0.0677	CrCbGaD
Benzphetamine—Selegiline—ABCB1—ovarian cancer	0.000301	0.0644	CrCbGaD
Benzphetamine—Diarrhoea—Epirubicin—ovarian cancer	0.000301	0.00276	CcSEcCtD
Benzphetamine—Hypersensitivity—Doxorubicin—ovarian cancer	0.0003	0.00275	CcSEcCtD
Benzphetamine—Dizziness—Epirubicin—ovarian cancer	0.000291	0.00267	CcSEcCtD
Benzphetamine—Bepridil—ABCB1—ovarian cancer	0.000282	0.0603	CrCbGaD
Benzphetamine—Diarrhoea—Doxorubicin—ovarian cancer	0.000278	0.00255	CcSEcCtD
Benzphetamine—Headache—Epirubicin—ovarian cancer	0.000275	0.00253	CcSEcCtD
Benzphetamine—Dizziness—Doxorubicin—ovarian cancer	0.000269	0.00247	CcSEcCtD
Benzphetamine—Nausea—Epirubicin—ovarian cancer	0.000261	0.0024	CcSEcCtD
Benzphetamine—Fentanyl—ABCB1—ovarian cancer	0.00026	0.0555	CrCbGaD
Benzphetamine—Headache—Doxorubicin—ovarian cancer	0.000255	0.00234	CcSEcCtD
Benzphetamine—Nausea—Doxorubicin—ovarian cancer	0.000242	0.00222	CcSEcCtD
Benzphetamine—Phenytoin—ABCB1—ovarian cancer	0.000236	0.0503	CrCbGaD
Benzphetamine—Trimipramine—ABCB1—ovarian cancer	0.000188	0.0401	CrCbGaD
Benzphetamine—Promethazine—ABCB1—ovarian cancer	0.000181	0.0386	CrCbGaD
Benzphetamine—Tamoxifen—ABCB1—ovarian cancer	0.00018	0.0384	CrCbGaD
Benzphetamine—Methadone—ABCB1—ovarian cancer	0.000178	0.0381	CrCbGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.97e-05	0.00171	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—NME2—ovarian cancer	5.88e-05	0.00169	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HSD17B6—ovarian cancer	5.78e-05	0.00166	CbGpPWpGaD
Benzphetamine—ADRA1A—AMPK Signaling—TP53—ovarian cancer	5.78e-05	0.00166	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.76e-05	0.00165	CbGpPWpGaD
Benzphetamine—ADRA1A—G alpha (12/13) signalling events—PIK3CA—ovarian cancer	5.59e-05	0.0016	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—NME2—ovarian cancer	5.51e-05	0.00158	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HSD17B6—ovarian cancer	5.37e-05	0.00154	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—ovarian cancer	5.36e-05	0.00154	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.29e-05	0.00152	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—HRAS—ovarian cancer	5.11e-05	0.00147	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.11e-05	0.00147	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—SPARC—ovarian cancer	4.99e-05	0.00143	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—DLC1—ovarian cancer	4.92e-05	0.00141	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—MAPK1—ovarian cancer	4.88e-05	0.0014	CbGpPWpGaD
Benzphetamine—ADRA1A—AMPK Signaling—AKT1—ovarian cancer	4.88e-05	0.0014	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	4.68e-05	0.00134	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—DLC1—ovarian cancer	4.57e-05	0.00131	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.55e-05	0.00131	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	4.12e-05	0.00118	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	4.11e-05	0.00118	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	4.05e-05	0.00116	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.03e-05	0.00116	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—BCL9—ovarian cancer	4.01e-05	0.00115	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—HRAS—ovarian cancer	3.92e-05	0.00112	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.8e-05	0.00109	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYTB—ovarian cancer	3.79e-05	0.00109	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—BCL9—ovarian cancer	3.72e-05	0.00107	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—SOD1—ovarian cancer	3.62e-05	0.00104	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PPP2R1A—ovarian cancer	3.61e-05	0.00103	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	3.59e-05	0.00103	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYTB—ovarian cancer	3.55e-05	0.00102	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—BRIP1—ovarian cancer	3.31e-05	0.00095	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PPP1CC—ovarian cancer	3.31e-05	0.00095	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—IL2—ovarian cancer	3.29e-05	0.000946	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—CXCL8—ovarian cancer	3.28e-05	0.000942	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—DOK1—ovarian cancer	3.17e-05	0.000909	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PPP1CC—ovarian cancer	3.1e-05	0.000891	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—BRIP1—ovarian cancer	3.1e-05	0.000891	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—HRAS—ovarian cancer	3.05e-05	0.000875	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—ovarian cancer	3.04e-05	0.000873	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PPP1CC—ovarian cancer	2.98e-05	0.000855	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—DOK1—ovarian cancer	2.94e-05	0.000845	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—ovarian cancer	2.91e-05	0.000837	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—MAPK1—ovarian cancer	2.91e-05	0.000835	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	2.81e-05	0.000806	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	2.8e-05	0.000804	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—ovarian cancer	2.77e-05	0.000796	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—ovarian cancer	2.77e-05	0.000796	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PPP1CC—ovarian cancer	2.77e-05	0.000794	CbGpPWpGaD
Benzphetamine—ADRA1A—G alpha (q) signalling events—PIK3CA—ovarian cancer	2.69e-05	0.000772	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—CAV1—ovarian cancer	2.65e-05	0.000761	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	2.65e-05	0.00076	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—ovarian cancer	2.62e-05	0.000752	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	2.61e-05	0.000749	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	2.52e-05	0.000723	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NME2—ovarian cancer	2.5e-05	0.000719	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PIK3CG—ovarian cancer	2.41e-05	0.000693	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	2.41e-05	0.000691	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—HRAS—ovarian cancer	2.34e-05	0.000671	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HDAC6—ovarian cancer	2.26e-05	0.000648	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PPP2R1A—ovarian cancer	2.23e-05	0.000639	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	2.23e-05	0.000639	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—YAP1—ovarian cancer	2.22e-05	0.000637	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	2.19e-05	0.000628	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CXCL8—ovarian cancer	2.14e-05	0.000614	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	2.13e-05	0.000612	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PIK3CD—ovarian cancer	2.12e-05	0.000609	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HDAC6—ovarian cancer	2.1e-05	0.000602	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—YAP1—ovarian cancer	2.08e-05	0.000597	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PPP2R1A—ovarian cancer	2.07e-05	0.000594	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—YAP1—ovarian cancer	2e-05	0.000573	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CXCL8—ovarian cancer	1.99e-05	0.00057	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—XIAP—ovarian cancer	1.96e-05	0.000562	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SMARCA4—ovarian cancer	1.91e-05	0.000548	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EREG—ovarian cancer	1.86e-05	0.000534	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—YAP1—ovarian cancer	1.86e-05	0.000533	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PIK3CB—ovarian cancer	1.85e-05	0.000531	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—XIAP—ovarian cancer	1.82e-05	0.000522	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—FASN—ovarian cancer	1.81e-05	0.000519	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	1.79e-05	0.000513	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—SLC5A5—ovarian cancer	1.78e-05	0.000511	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SMARCA4—ovarian cancer	1.77e-05	0.000509	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PGR—ovarian cancer	1.74e-05	0.000501	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EREG—ovarian cancer	1.73e-05	0.000497	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—SLC2A1—ovarian cancer	1.72e-05	0.000494	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—IL2—ovarian cancer	1.7e-05	0.000487	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—FASN—ovarian cancer	1.7e-05	0.000487	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SLC5A5—ovarian cancer	1.67e-05	0.000479	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP1B1—ovarian cancer	1.65e-05	0.000473	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PIK3CG—ovarian cancer	1.64e-05	0.000471	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PARP1—ovarian cancer	1.62e-05	0.000466	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PGR—ovarian cancer	1.62e-05	0.000465	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYTB—ovarian cancer	1.61e-05	0.000463	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SLC2A1—ovarian cancer	1.61e-05	0.000463	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL6ST—ovarian cancer	1.55e-05	0.000445	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP1B1—ovarian cancer	1.55e-05	0.000444	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PIK3CG—ovarian cancer	1.53e-05	0.000438	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PARP1—ovarian cancer	1.51e-05	0.000433	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PIK3CG—ovarian cancer	1.49e-05	0.000428	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PPP2R1A—ovarian cancer	1.46e-05	0.00042	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—VEGFA—ovarian cancer	1.44e-05	0.000414	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PIK3CD—ovarian cancer	1.44e-05	0.000414	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL6ST—ovarian cancer	1.44e-05	0.000414	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—NRAS—ovarian cancer	1.43e-05	0.000409	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.41e-05	0.000405	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.41e-05	0.000405	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3CG—ovarian cancer	1.39e-05	0.000398	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	1.37e-05	0.000393	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—MAPK3—ovarian cancer	1.37e-05	0.000392	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ABCB1—ovarian cancer	1.36e-05	0.00039	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PIK3CD—ovarian cancer	1.34e-05	0.000385	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—TYMS—ovarian cancer	1.33e-05	0.000383	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PPP2R1A—ovarian cancer	1.32e-05	0.000378	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PIK3CD—ovarian cancer	1.31e-05	0.000376	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—MAPK1—ovarian cancer	1.3e-05	0.000373	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ABCB1—ovarian cancer	1.27e-05	0.000365	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PIK3CB—ovarian cancer	1.26e-05	0.000361	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—TYMS—ovarian cancer	1.25e-05	0.000359	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—KRAS—ovarian cancer	1.23e-05	0.000352	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PPP2R1A—ovarian cancer	1.22e-05	0.000351	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3CD—ovarian cancer	1.22e-05	0.000349	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CXCL8—ovarian cancer	1.21e-05	0.000347	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PIK3CB—ovarian cancer	1.17e-05	0.000335	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—IL2—ovarian cancer	1.16e-05	0.000332	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PIK3CB—ovarian cancer	1.14e-05	0.000328	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PIK3CA—ovarian cancer	1.13e-05	0.000324	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CXCL8—ovarian cancer	1.12e-05	0.000322	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CXCL8—ovarian cancer	1.1e-05	0.000315	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TP53—ovarian cancer	1.09e-05	0.000313	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CAV1—ovarian cancer	1.07e-05	0.000308	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—IL2—ovarian cancer	1.07e-05	0.000308	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3CB—ovarian cancer	1.06e-05	0.000305	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL2—ovarian cancer	1.05e-05	0.000301	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TERT—ovarian cancer	1.05e-05	0.0003	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—HRAS—ovarian cancer	1.04e-05	0.000299	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CXCL8—ovarian cancer	1.02e-05	0.000293	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CAV1—ovarian cancer	1.01e-05	0.000289	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CG—ovarian cancer	9.79e-06	0.000281	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL2—ovarian cancer	9.75e-06	0.00028	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TERT—ovarian cancer	9.71e-06	0.000279	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CAV1—ovarian cancer	9.67e-06	0.000277	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—YAP1—ovarian cancer	9.46e-06	0.000271	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ESR1—ovarian cancer	9.32e-06	0.000267	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—AKT1—ovarian cancer	9.21e-06	0.000264	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CG—ovarian cancer	9.17e-06	0.000263	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL6ST—ovarian cancer	9.16e-06	0.000263	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CAV1—ovarian cancer	8.98e-06	0.000258	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APC—ovarian cancer	8.81e-06	0.000253	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CG—ovarian cancer	8.81e-06	0.000253	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—NRAS—ovarian cancer	8.81e-06	0.000253	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ESR1—ovarian cancer	8.66e-06	0.000248	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CD—ovarian cancer	8.6e-06	0.000247	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL6ST—ovarian cancer	8.52e-06	0.000244	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—MAPK3—ovarian cancer	8.43e-06	0.000242	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CG—ovarian cancer	8.18e-06	0.000235	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APC—ovarian cancer	8.18e-06	0.000235	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—NRAS—ovarian cancer	8.18e-06	0.000235	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CD—ovarian cancer	8.06e-06	0.000231	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—MAPK1—ovarian cancer	8.02e-06	0.00023	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—EGFR—ovarian cancer	8.02e-06	0.00023	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—MAPK3—ovarian cancer	7.84e-06	0.000225	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CD—ovarian cancer	7.74e-06	0.000222	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—FASN—ovarian cancer	7.71e-06	0.000221	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PIK3CA—ovarian cancer	7.67e-06	0.00022	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	7.58e-06	0.000218	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—KRAS—ovarian cancer	7.58e-06	0.000218	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CB—ovarian cancer	7.5e-06	0.000215	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—MAPK1—ovarian cancer	7.46e-06	0.000214	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—EGFR—ovarian cancer	7.45e-06	0.000214	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	7.33e-06	0.00021	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CD—ovarian cancer	7.19e-06	0.000206	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PIK3CA—ovarian cancer	7.12e-06	0.000204	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—KRAS—ovarian cancer	7.04e-06	0.000202	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CB—ovarian cancer	7.03e-06	0.000202	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	7.02e-06	0.000202	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PIK3CA—ovarian cancer	6.96e-06	0.0002	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ERBB2—ovarian cancer	6.84e-06	0.000196	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MTOR—ovarian cancer	6.75e-06	0.000194	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CB—ovarian cancer	6.75e-06	0.000194	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CXCL8—ovarian cancer	6.48e-06	0.000186	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTEN—ovarian cancer	6.48e-06	0.000186	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3CA—ovarian cancer	6.47e-06	0.000186	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—HRAS—ovarian cancer	6.44e-06	0.000185	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ERBB2—ovarian cancer	6.35e-06	0.000182	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CDKN1B—ovarian cancer	6.33e-06	0.000182	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MTOR—ovarian cancer	6.27e-06	0.00018	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CB—ovarian cancer	6.27e-06	0.00018	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—AKT1—ovarian cancer	6.26e-06	0.00018	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	6.23e-06	0.000179	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CASP3—ovarian cancer	6.21e-06	0.000178	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL2—ovarian cancer	6.2e-06	0.000178	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL6—ovarian cancer	6.17e-06	0.000177	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTEN—ovarian cancer	6.07e-06	0.000174	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCND1—ovarian cancer	6.04e-06	0.000173	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CXCL8—ovarian cancer	6.02e-06	0.000173	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—HRAS—ovarian cancer	5.99e-06	0.000172	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CTNNB1—ovarian cancer	5.98e-06	0.000172	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CDKN1B—ovarian cancer	5.88e-06	0.000169	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MMP9—ovarian cancer	5.86e-06	0.000168	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTEN—ovarian cancer	5.83e-06	0.000167	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—AKT1—ovarian cancer	5.82e-06	0.000167	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ABCB1—ovarian cancer	5.78e-06	0.000166	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CASP3—ovarian cancer	5.77e-06	0.000166	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL2—ovarian cancer	5.76e-06	0.000165	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL6—ovarian cancer	5.73e-06	0.000164	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—AKT1—ovarian cancer	5.69e-06	0.000163	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—TYMS—ovarian cancer	5.68e-06	0.000163	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCND1—ovarian cancer	5.61e-06	0.000161	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CTNNB1—ovarian cancer	5.56e-06	0.00016	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MMP9—ovarian cancer	5.45e-06	0.000156	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTEN—ovarian cancer	5.42e-06	0.000155	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AKT1—ovarian cancer	5.29e-06	0.000152	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—VEGFA—ovarian cancer	5.27e-06	0.000151	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—STAT3—ovarian cancer	5.21e-06	0.00015	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NRAS—ovarian cancer	5.2e-06	0.000149	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MAPK3—ovarian cancer	4.98e-06	0.000143	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—VEGFA—ovarian cancer	4.89e-06	0.00014	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MYC—ovarian cancer	4.85e-06	0.000139	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—STAT3—ovarian cancer	4.85e-06	0.000139	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NRAS—ovarian cancer	4.83e-06	0.000139	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MAPK1—ovarian cancer	4.74e-06	0.000136	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EGFR—ovarian cancer	4.74e-06	0.000136	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MAPK3—ovarian cancer	4.63e-06	0.000133	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CAV1—ovarian cancer	4.58e-06	0.000131	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CA—ovarian cancer	4.57e-06	0.000131	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MYC—ovarian cancer	4.5e-06	0.000129	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KRAS—ovarian cancer	4.48e-06	0.000129	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MAPK1—ovarian cancer	4.4e-06	0.000126	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EGFR—ovarian cancer	4.4e-06	0.000126	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CA—ovarian cancer	4.29e-06	0.000123	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	4.17e-06	0.00012	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KRAS—ovarian cancer	4.16e-06	0.000119	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CA—ovarian cancer	4.11e-06	0.000118	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TP53—ovarian cancer	3.98e-06	0.000114	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CA—ovarian cancer	3.82e-06	0.00011	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HRAS—ovarian cancer	3.81e-06	0.000109	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—AKT1—ovarian cancer	3.73e-06	0.000107	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TP53—ovarian cancer	3.7e-06	0.000106	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.66e-06	0.000105	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL6—ovarian cancer	3.64e-06	0.000105	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HRAS—ovarian cancer	3.54e-06	0.000101	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—AKT1—ovarian cancer	3.5e-06	0.0001	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL6—ovarian cancer	3.38e-06	9.71e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AKT1—ovarian cancer	3.36e-06	9.65e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	3.19e-06	9.17e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AKT1—ovarian cancer	3.12e-06	8.96e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTEN—ovarian cancer	2.76e-06	7.92e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.95e-06	5.59e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AKT1—ovarian cancer	1.59e-06	4.57e-05	CbGpPWpGaD
